top biopharmaceuticals for glp-1 medication Drugmakers are racing to find the next Wegovy. These obesity trials are ones to watch Emerging New Drug Modalities in

There is also more public awareness around weight management therapies and the presence of leading pharmaceutical companies , which in turn keeps strengthening market development and adoption of GLP-1 agonist treatments

Other GLP-1 Pills in the Pipeline Although Wegovy is the first GLP-1 pill the FDA has approved for weight management, drug manufacturers are funding trials for additional oral GLP-1 medications

More indications are in advanced stages of clinical development, such as chronic spontaneous urticaria, unexplained chronic itching, pemphigoid, and ulcerative colitis

Since then, the landscape has seen numerous entries and exits, leaving Novo Nordisk and Eli Lilly as the primary players